Impact of obesity on COVID-19 CoronaVac and ChAdOx1-S vaccine efficacy.

Impact of obesity on COVID-19 CoronaVac and ChAdOx1-S vaccine efficacy.

Publication date: Dec 09, 2025

Open Access PDF

Concepts Keywords
Chadox1 Bioimpedance
Covid Body composition
Obesity ChAdOx1-S
Vaccines CoronaVac
COVID-19
Immunogenicity
Obesity
Vaccine efficacy

Semantics

Type Source Name
disease MESH obesity
disease MESH COVID-19
disease MESH Infectious Diseases
disease MESH Dis
disease MESH Mota
drug DRUGBANK L-Valine
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Coenzyme M
disease MESH death
disease MESH metabolic diseases
disease MESH inflammation
disease MESH respiratory infections
disease MESH hypertension
disease MESH infection
disease MESH overweight
disease MESH plan
disease MESH fever
disease MESH chronic illnesses
disease MESH autoimmune diseases
drug DRUGBANK BIA
disease MESH severe obesity
disease MESH Ito

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *